These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15751270)

  • 1. Living-donor liver transplantation: present status and future perspective.
    Shimada M; Fujii M; Morine Y; Imura S; Ikemoto T; Ishibashi H
    J Med Invest; 2005 Feb; 52(1-2):22-32. PubMed ID: 15751270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.
    Yoon YI; Song GW; Lee SG; Hwang S; Kim KH; Kim SH; Kang WH; Cho HD; Jwa EK; Kwon JH; Tak EY; Kirchner VA
    J Hepatol; 2018 Jun; 68(6):1153-1162. PubMed ID: 29452208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Living donor liver transplantation].
    Tanaka K; Kaihara S
    Chirurg; 2003 Oct; 74(10):944-50. PubMed ID: 14605737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplantation in Asia: past, present and future.
    Ng KK; Lo CM
    Ann Acad Med Singap; 2009 Apr; 38(4):322-10. PubMed ID: 19434335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABO-incompatible Living Donor Liver Transplantation With Rituximab and Total Plasma Exchange Does Not Increase Hepatocellular Carcinoma Recurrence.
    Kim JM; Kwon CHD; Joh JW; Han S; Yoo J; Kim K; Sinn DH; Choi GS; Gerber DA; Egawa H; Lee SK
    Transplantation; 2018 Oct; 102(10):1695-1701. PubMed ID: 29494419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in living donor liver transplantation.
    Trotter JF
    Clin Liver Dis; 2014 Aug; 18(3):651-60. PubMed ID: 25017081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Living donor liver transplantation for hepatocellular carcinoma.
    Lee SG; Moon DB
    Recent Results Cancer Res; 2013; 190():165-79. PubMed ID: 22941020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABO-incompatible adult living donor liver transplantation for hepatocellular carcinoma.
    Matsuno N; Iwamoto H; Nakamura Y; Hama K; Kihara Y; Konno O; Jojima Y; Akashi I; Mijiti A; Ashizawa T; Nagao T
    Transplant Proc; 2008 Oct; 40(8):2497-500. PubMed ID: 18929778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report.
    Nakamura Y; Hama K; Iwamoto H; Yokoyama T; Kihara Y; Konno O; Jojima Y; Shimazu M
    Transplant Proc; 2012 Mar; 44(2):565-9. PubMed ID: 22410070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Living donor liver transplantation.
    Goldaracena N; Barbas AS
    Curr Opin Organ Transplant; 2019 Apr; 24(2):131-137. PubMed ID: 30694993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.
    Terrault NA; Shiffman ML; Lok AS; Saab S; Tong L; Brown RS; Everson GT; Reddy KR; Fair JH; Kulik LM; Pruett TL; Seeff LB;
    Liver Transpl; 2007 Jan; 13(1):122-9. PubMed ID: 17192908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Living donor liver transplantation: present status and recent advances.
    Sugawara Y; Makuuchi M
    Br Med Bull; 2005; 75-76():15-28. PubMed ID: 16474043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of ABO-incompatibility on hepatocellular carcinoma recurrence after living donor liver transplantation.
    Kim SH; Lee EC; Na BG; Park SJ
    Eur J Surg Oncol; 2019 Feb; 45(2):180-186. PubMed ID: 30243467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
    Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS
    Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation.
    Kozaki K; Egawa H; Kasahara M; Oike F; Yoshizawa A; Fukatsu A; Tanaka K
    Ther Apher Dial; 2005 Aug; 9(4):285-91. PubMed ID: 16076368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role and limitation of living donor liver transplantation for hepatocellular carcinoma.
    Lo CM; Fan ST; Liu CL; Chan SC; Wong J
    Liver Transpl; 2004 Mar; 10(3):440-7. PubMed ID: 15004774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of organ transplantation in Japan and worldwide.
    Yoshimura N; Okajima H; Ushigome H; Sakamoto S; Fujiki M; Okamoto M
    Surg Today; 2010 Jun; 40(6):514-25. PubMed ID: 20496132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: a meta-analysis.
    Liang W; Wu L; Ling X; Schroder PM; Ju W; Wang D; Shang Y; Kong Y; Guo Z; He X
    Liver Transpl; 2012 Oct; 18(10):1226-36. PubMed ID: 22685095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplantation: past, present and future.
    Zarrinpar A; Busuttil RW
    Nat Rev Gastroenterol Hepatol; 2013 Jul; 10(7):434-40. PubMed ID: 23752825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of plasmapheresis therapy for perioperative management in ABO-incompatible adult living donor liver transplantation.
    Ashizawa T; Matsuno N; Yokoyama T; Kihara Y; Kuzuoka K; Taira S; Konno O; Jyojima Y; Akashi I; Nakamura Y; Hama K; Iwamoto H; Iwahori T; Nagao T; Kasahara M; Tanaka K
    Transplant Proc; 2006 Dec; 38(10):3629-32. PubMed ID: 17175351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.